Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
Orthofix Medical Inc. (OFIX) will report its Q4 and full year 2023 financial results on March 5, 2024. A conference call and webcast will follow to discuss the outcomes.
02/21/2024 - 07:00 AM
LEWISVILLE, Texas --(BUSINESS WIRE)--
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close. The Company will host a conference call and webcast to review results at 4:30 p.m. ET the same day.
Interested parties may access the conference call by dialing (888) 330-2508 in the U.S. , and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S. , and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com .
About Orthofix:
Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.
The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA , with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy , with an emphasis on product innovation, production, and medical education for orthopedics. The combined Company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA , Toronto, Canada , Sunnyvale, CA , Wayne, PA , Olive Branch, MS , Maidenhead, UK , Munich, Germany , Paris, France and Sao Paulo, Brazil .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221053940/en/
Investor Relations
Louisa Smith, Gilmartin Group
ir@orthofix.com
Source: Orthofix Medical Inc.
When will Orthofix Medical Inc. release its Q4 and full year 2023 financial results?
Orthofix Medical Inc. (OFIX) will release its Q4 and full year 2023 financial results on Tuesday, March 5, 2024 after market close.
How can interested parties access the conference call?
Interested parties can access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380.
Is there a replay option for the conference call?
Yes, a replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S., and (647) 362-9199 in all other locations, and entering the event passcode 9556380.
Where can a webcast of the conference call and a copy of the release be accessed?
A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.
OFIX Rankings
#4011 Ranked by Stock Gains
OFIX Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
About OFIX
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing